Neratinib plus paclitaxel vs. trastuzumab plus paclitaxel in breast cancer The …

Neratinib plus paclitaxel vs. trastuzumab plus paclitaxel in breast cancer The …

While neratinib plus paclitaxel was not superior to trastuzumab plus paclitaxel as first-line treatment for ERBB2-positive metastatic breast cancer in terms of progression-free survival, the combination was associated with delayed onset and reduced

(Visited 3 times, 1 visits today)
5
Like
Save

Comments

Write a comment